维普期刊资源整合服务平台（V6.5）

24篇 您的检索式：作者名="Papaldo"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Lonidamine:efficacy and safety in clinical trials for the treatment of solid tumors显示文摘	Di Cosimo S Ferretti G Papaldo P		0，，3：	1
2	Phase Ⅱ study on metastatic breast cancer patients treated with weekly vinorelbine with or without trastuzumab according to HER2 expression:changing the natural history of HER2-positive disease 显示文摘	Papaldo P Fabi A Ferretti G	2006	Ann Oncol2006，17，4：	1
3	HER2/neu role in breast cancer: from a prognostic foe to a predictive friend显示文摘	Ferretti G Feliei A Papaldo P	2007	Curr Opin Obstet Gynecol2007，19，1：	1
4	Phase Ⅱ study on metastatic breast cancer patients treated with weekly vinorelbine with or without trastuzumab according to HER2 expression: changing the natural history of HER2-positive disease显示文摘	Papaldo P Fabi A Ferretti G	2006	Ann Oncol2006，17，4：	1
5	Lonidamine , efficacy and safety in clinical trials for the treatment of solid tumors 显示文摘	Di Cosimo S Ferretti G Papaldo P	2003	Drugs Today2003，39，3：	1
6	HER2/neu role in breast cancer: from a prognostic foe to a predictive friend显示文摘	Ferretti G Felici A Papaldo P	2007	Curr Opin Obstet Gynecol2007，19，1：	1
7	Pegylated liposomal doxorubicin in combination with gemcitabine:a phase Ⅱ study in anthracycline-na?ve and anthracycline pretreated metastatic breast cancer patients显示文摘	Fabi A Ferretti G Papaldo P	2006	Cancer Chemother Pharmacol2006，57，5：	1
8	HER2/neu role in breast cancer:from a prognostic foe to a predictive friend显示文摘	Ferretti G Felici A Papaldo P	2007	Curr Opin Obstet Gynecol2007，19，1：	1
9	A phase II study on metastatic breast cancer patients treated with weekly vinorelbine with or without trastuzumab according to HER2 expression: changing the natural history of HER2-positive disease 显示文摘	Papaldo P Fabi A Ferretti G	2006	Ann Oncol2006，17，4：	1
10	Impact of celecoxib on eapeeitabine tolerability and activity in pretreated metastatic breast cancer: results of a phase 11 study with biomarker evaluation 显示文摘	Fabi A Metro G Papaldo P	2008	Cancer Chemother Pharmacol2008，62，4：	1
11	Impact of celecoxib on capecitabine tolerability and activity in pretreated metastatic breast cancer: results of a phase Ⅱ study with biomarker evaluation显示文摘	Fabi A Metro G Papaldo P	2008	Cancer Chemother Pharmaeol2008，62，4：	1
12	Phase Ⅱ study on metastatic breast cancer patients treated with weekly vinorelbine with or without trastuzumab according to HER2 expression: changing the natural history of HER2-positive disease 显示文摘	Papaldo P Fabi A Ferretti G a al	2006	Ann Oncol2006，17，4：	1
13	Liver toxicity after treatment with gefitinib and anastrozole: drug-drug interactions through cytochrome p4507 显示文摘	Carlini P Papaldo P Fabi A	2006	J Clin Oncol2006，24，35：	1
14	Impact of celecoxib on capecitabine tolerability and activity in pretreated metastatic breast cancer: results of a phase I1 study with biomarker evaluation 显示文摘	Fabi A Metro G Papaldo P	2008	Cancer Chemother Pharmacol2008，62，4：	1
15	Phase II study on metastatic breast cancer patients treated with weekly vinorelbine with or without trastuzumab according to HEE2 expression:changing the n ural history of HER2-positive disease显示文摘	Papaldo P Fabi A Ferretti O	2006	Ann Oncol2006，17，4：	1
16	Impact of celecoxib oncapecitabine tolerability and activity in pretreated metastaticbreast cancer:results of a phase II study with biomarker e-valuation显示文摘	Fabi A Metro G Papaldo P	2008	Cancer Chemother Pharmacol2008，62，4：	1
17	Pegylated liposomal doxorubicin in combination with gemcitabine: a phase II study in anthracycline - naive and anthracycline pretreated metastatic breast cancer patients 显示文摘	FABI A FERRETTI G PAPALDO P	2006	Cancer Chemother Pharmacol2006，57，5：	1
18	HER2/neu role in breast cancer: from a prognostic foe to a predictive friend显示文摘	Ferreni G Feliei A Papaldo P	2007	Carr Opin Obstet Gynecol2007，19，1：	1
19	Does granulocyte colony-stimulating factor worsen anemia in early breast cancer patientstreated with epirubicin and cyclophosphamide显示文摘	Papaldo P Ferretti G Di Cosimo	2006	J Clin Oncol2006，24，：	1
20	HER2/neu role in breast cancer: from a prognostic foe to apredictive friend 显示文摘	Ferretti G Felici A Papaldo P	2007	Curr Opin Obstet Gynecol2007，19，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示